Inhibition of methicillin-resistant Staphylococcus aureus (MRSA) biofilm by cationic poly (D, L-lactide-co-glycolide) nanoparticles

References

• Astete CE, Sabliov CM. 2006. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci, Polym Ed. 17:247–289. doi:10.1163/156856206775997322
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, et al. 2015. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American heart association. Circulation. 132:1435–1486. doi:10.1161/CIR.0000000000000296
   PubMed Web of Science ®Google Scholar
• Brackman G, Breyne K, De RR, Vermote A, Van NF, Meyer E, Van CS, Coenye T. 2016. The quorum sensing inhibitor hamamelitannin increases antibiotic susceptibility of Staphylococcus aureus biofilms by affecting peptidoglycan biosynthesis and eDNA release. Sci Rep. 6:20321. doi:10.1038/srep20321
   PubMed Web of Science ®Google Scholar
• Cafiso V, Bertuccio T, Spina D, Purrello S, Campanile F, Di PC, Purrello M, Stefani S. 2012. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains. PLoS One. 7:e29573. doi:10.1371/journal.pone.0029573
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR. 51:565–567.
   PubMedGoogle Scholar
• Chambers HF, Deleo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 7:629–641. doi:10.1038/nrmicro2200
   PubMed Web of Science ®Google Scholar
• Cheng AG, DeDent AC, Schneewind O, Missiakas D. 2011. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. 19:225–232. doi:10.1016/j.tim.2011.01.007
   PubMed Web of Science ®Google Scholar
• Cheng Y, Yang H, Yang Y, Huang JY, Wu K, Chen Z, Wang XQ, Lin CJ, Lai YK. 2018. Progress in TiO2 nanotube coatings for biomedical applications: a review. J Mater Chem B. 6:1862–1886. doi:10.1039/C8TB00149A
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science (New York, NY). 284:1318–1322. doi:10.1126/science.284.5418.1318
   Google Scholar
• Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, et al. 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 173:1970–1978.
   PubMed Web of Science ®Google Scholar
• Frieri M, Kumar K, Boutin A. 2015. Review: immunology of sinusitis, trauma, asthma, and sepsis. Allergy Rhinol (Providence). 6:205–214. doi:10.2500/ar.2015.6.0140
   PubMed Web of Science ®Google Scholar
• Gardete S, Tomasz A. 2014. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest. 124:2836–2840. doi:10.1172/JCI68834
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (London, England). 350:1670–1673. doi:10.1016/S0140-6736(97)07324-8
   PubMed Web of Science ®Google Scholar
• Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. PNAS. 101:9786–9791. doi:10.1073/pnas.0402521101
   PubMed Web of Science ®Google Scholar
• Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. 2015. PLGA: a unique polymer for drug delivery. Therap Deliv. 6:41–58. doi:10.4155/tde.14.91
   PubMed Web of Science ®Google Scholar
• Lash DB, Joson J, Heidari A. 2015. Differences in method-specific vancomycin MICs and induced daptomycin resistance in an infective endocarditis patient. Case Rep Infect Dis. 2015:1–3.
   Google Scholar
• Lee AS, de LH, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S. 2018. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 4:18033. doi:10.1038/nrdp.2018.33
   PubMed Web of Science ®Google Scholar
• Li X, Huang W, Zheng X, Chang S, Liu C, Cheng Q, Zhu S. 2019. Synergistic in vitro effects of indocyanine green and ethylenediamine tetraacetate-mediated antimicrobial photodynamic therapy combined with antibiotics for resistant bacterial biofilms in diabetic foot infection. Photodiagn Photodyn Ther. 25:300–308. doi:10.1016/j.pdpdt.2019.01.010
   PubMed Web of Science ®Google Scholar
• Li JM, Xue SS, Mao ZW. 2016. Nanoparticle delivery systems for siRNA-based therapeutics. J Mater Chem B. 4:6620–6639. doi:10.1039/C6TB01462C
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, et al. 2011. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 52:285–292. doi:10.1093/cid/cir034
   PubMed Web of Science ®Google Scholar
• Liu J, Peng Q. 2017. Protein-gold nanoparticle interactions and their possible impact on biomedical applications. Acta Biomater. 55:13–27. doi:10.1016/j.actbio.2017.03.055
   PubMed Web of Science ®Google Scholar
• López Díaz MC, Ríos E, Rodríguez-Avial I, Simaluiza RJ, Picazo JJ, Culebras E. 2017. In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents. Int J Antimicrob Agents. 50:191–196. doi:10.1016/j.ijantimicag.2017.01.039
   PubMed Web of Science ®Google Scholar
• McGuinness WA, Malachowa N, DeLeo FR. 2017. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 90:269–281.
   PubMed Web of Science ®Google Scholar
• Miceli E, Kar M, Calderon M. 2017. Interactions of organic nanoparticles with proteins in physiological conditions. J Mater Chem B. 5:4393–4405. doi:10.1039/C7TB00146K
   PubMed Web of Science ®Google Scholar
• Peng Q, Mu H. 2016. The potential of protein-nanomaterial interaction for advanced drug delivery. J Control Release. 225:121–132. doi:10.1016/j.jconrel.2016.01.041
   PubMed Web of Science ®Google Scholar
• Rai A, Senapati S, Saraf SK, Maiti P. 2016. Biodegradable poly(epsilon-caprolactone) as a controlled drug delivery vehicle of vancomycin for the treatment of MRSA infection. J Mater Chem B. 4:5151–5160. doi:10.1039/C6TB01623E
   PubMed Web of Science ®Google Scholar
• Shao XR, Wei XQ, Song X, Hao LY, Cai XX, Zhang ZR, Peng Q, Lin YF. 2015. Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells. Cell Prolif. 48:465–474. doi:10.1111/cpr.12192
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. 2018. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 18:318–327. doi:10.1016/S1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Thabit AK, Crandon JL, Nicolau DP. 2015. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opin Pharmacother. 16:159–177. doi:10.1517/14656566.2015.993381
   PubMed Web of Science ®Google Scholar
• Thomer L, Schneewind O, Missiakas D. 2016. Pathogenesis of Staphylococcus aureus bloodstream infections. Annu Rev Pathol Mech Dis. 11:343–364. doi:10.1146/annurev-pathol-012615-044351
   PubMed Web of Science ®Google Scholar
• Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Jr.2015. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 28:603–661. doi:10.1128/CMR.00134-14
   PubMed Web of Science ®Google Scholar
• Xia MY, Xie Y, Yu CH, Chen GY, Li YH, Zhang T, Peng Q. 2019. Graphene-based nanomaterials: the promising active agents for antibiotics-independent antibacterial applications. J Control Release. 307:16–31. doi:10.1016/j.jconrel.2019.06.011
   PubMed Web of Science ®Google Scholar
• Zhu GY, Lu BY, Zhang TX, Zhang T, Zhang CL, Li Y, Peng Q. 2018. Antibiofilm effect of drug-free and cationic poly (D, L-lactide-co-glycolide) nanoparticles via nano-bacteria interactions. Nanomedicine. 13:1093–1106. doi:10.2217/nnm-2017-0391
   PubMed Web of Science ®Google Scholar